Acute Exacerbations and Respiratory Failure in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) describe the phenomenon of sudden worsening in airway function and respiratory symptoms in patients with COPD. These exacerbations can range from self-limited diseases to episodes of florid respiratory failure requiring mechanical ventilation. The average patient with COPD experiences two such episodes annually, and they account for significant consumption of health care resources. Although bacterial infections are the most common causes of AECOPD, viral infections and environmental stresses are also implicated. AECOPD episodes can be triggered or complicated by other comorbidities, such as heart disease, other lung diseases (e.g., pulmonary emboli, aspiration, pneumothorax), or systemic processes. Pharmacologic management includes bronchodilators, corticosteroids, and antibiotics in most patients. Oxygen, physical therapy, mucolytics, and airway clearance devices may be useful in selected patients. In hypercapneic respiratory failure, noninvasive positive pressure ventilation may allow time for other therapies to work and thus avoid endotracheal intubation. If the patient requires invasive mechanical ventilation, the focus should be on avoiding ventilator-induced lung injury and minimizing intrinsic positive end-expiratory pressure. These may require limiting ventilation and “permissive hypercapnia.” Although mild episodes of AECOPD are generally reversible, more severe forms of respiratory failure are associated with a substantial mortality and a prolonged period of disability in survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
An association between air pollution and mortality in six U.S. cities
Dockery, D. W., Pope, C. A., Xu, X., Spengler, J. D., Ware, J. H., Fay, M. E., Ferris, B. G., & Speizer, F. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292401 · Cited by 8,018
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492 · cited 1×
“The traditional system uses the Winnipeg criteria, which were derived from a double-blind, placebo-controlled trial that evaluated the role of antibiotics in patients with COPD with acute exacerbations (42).”
MethodConnors, A. F., Dawson, N. V., Thomas, C., Harrell, F. E., Desbiens, N., Fulkerson, W. J., Kussin, P., Bellamy, P., Goldman, L., & Knaus, W. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887592 · Cited by 1,393
Chronic Obstructive Pulmonary Disease Surveillance—United States, 1971–2000
Mannino, D. M., Homa, D. M., Akinbami, L. J., Ford, E. S., & Redd, S. C. (2002) · Respiratory Care · doi:10.1177/002013240204701009 · Cited by 1,294 · cited 4×
“AECOPD episodes have been shown to accelerate FEV1 decline, to increase mortality (AECOPD episodes are the most common cause of death in COPD), and to have a profound influence on the decline in quality of life scores (4, 6, 73, 76).”
InfluentialEvidence-Based Guidelines for Weaning and Discontinuing Ventilatory Support
MacIntyre, N. R. (2001) · Chest · doi:10.1378/chest.120.6_suppl.375s · Cited by 1,240
Self-citationInfections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072 · cited 1×
“Patients with infectious exacerbations have longer hospitalizations and greater impairment of several measures of lung function than those with noninfectious exacerbations (8).”
BackgroundNew Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
Sethi, S., Evans, N., Grant, B. J. B., & Murphy, T. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012561 · Cited by 1,047
Lightowler, J. V., Wedzicha, J. A., Elliott, M. W., & Ram, F. S. F. (2003) · BMJ · doi:10.1136/bmj.326.7382.185 · Cited by 843 · cited 2×
“Evaluating this concept are a number of randomized and/or crossover studies using NPPV in the initial phases of severe AECOPD (56).”
BackgroundResultDevice Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
Dolovich, M. B., Ahrens, R. C., Hess, D. R., Anderson, P., Dhand, R., Rau, J. L., Smaldone, G. C., & Guyatt, G. (2005) · Chest · doi:10.1378/chest.127.1.335 · Cited by 794
Prognosis in Chronic Obstructive Pulmonary Disease 1– 3
Anthonisen, N. R., Wright, E. C., Hodgkin, J. E., & IPPB Trial Group (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.133.1.14 · Cited by 777
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Groenewegen, K. H., Schols, A. M. W. J., & Wouters, E. F. M. (2003) · Chest · doi:10.1378/chest.124.2.459 · Cited by 717 · cited 2×
“AECOPD episodes have been shown to accelerate FEV1 decline, to increase mortality (AECOPD episodes are the most common cause of death in COPD), and to have a profound influence on the decline in quality of life scores (4, 6, 73 , 76).”
BackgroundHickling, K. G., Walsh, J., Henderson, S., & Jackson, R. (1994) · Critical Care Medicine · doi:10.1097/00003246-199422100-00011 · Cited by 695
Nava, S., Ambrosino, N., Clini, E., Prato, M., Orlando, G., Vitacca, M., Brigada, P., Fracchia, C., & Rubini, F. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-9-199805010-00004 · Cited by 682
Seneff, M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230038027 · Cited by 593
Sullivan, S. D., Ramsey, S. D., & Lee, T. A. (2000) · Chest · doi:10.1378/chest.117.2_suppl.5s · Cited by 579
Monsó, E., Ruiz, J., Rosell, A., Manterola, J., Fiz, J., Morera, J., & Ausina, V (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551388 · Cited by 562
Health effects of particulate air pollution: time for reassessment?
Pope, C. A., Bates, D. V., & Raizenne, M. E. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103472 · Cited by 528
Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction
Smith, T. C., & Marini, J. J. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.65.4.1488 · Cited by 511
Tidal Volume Reduction in Patients with Acute Lung Injury When Plateau Pressures Are Not High
Hager, D. N., Krishnan, J. A., Hayden, D. L., & Brower, R. G. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-048cp · Cited by 509
Exacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462 · cited 1×
“AECOPD episodes have been shown to accelerate FEV1 decline, to increase mortality (AECOPD episodes are the most common cause of death in COPD), and to have a profound influence on the decline in quality of life scores (4, 6, 73, 76).”
BackgroundUse of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
&NA; (2001) · Survey of Anesthesiology · doi:10.1097/00132586-200102000-00017 · Cited by 453
Ventilation-perfusion inequality in chronic obstructive pulmonary disease.
Wagner, P. D., Dantzker, D. R., Dueck, R., Clausen, J. L., & West, J. B. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108630 · Cited by 445 · cited 2×
“Q relationships, oxygen therapy should be targeted to provide the minimal amount to maintain acceptable oxygenation (e.g., SpO2 values of .89%) ( 37 , 38).”
BackgroundAnderson, H., Spix, C., Medina, S., Schouten, J., Castellsague, J., Rossi, G., Zmirou, D., Touloumi, G., Wojtyniak, B., Ponka, A., et al. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10051064 · Cited by 424
Gajic, O., Frutos-Vivar, F., Esteban, A., Hubmayr, R. D., & Anzueto, A. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2625-1 · Cited by 382 · cited 2×
“Clinically this occurs when the end-inspiratory stretching pressure (often estimated by the end-inspiratory airway plateau pressure) exceeds the normal physiological maximum of 30 cm H2O (54).”
BackgroundGIRAULT, C., DAUDENTHUN, I., CHEVRON, V., TAMION, F., LEROY, J., & BONMARCHAND, G. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9802120 · Cited by 365
Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations: A Meta-analysis
Saint, S. (1995) · JAMA · doi:10.1001/jama.1995.03520360071042 · Cited by 365
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease
Seemungal, T. A. R., Harper-Owen, R., Bhowmik, A., Jeffries, D. J., & Wedzicha, J. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d19.x · Cited by 334
Ventilator-induced lung injury:from the bench to the bedside
Tremblay, L. N., & Slutsky, A. S. (2009) · Applied Physiology in Intensive Care Medicine · doi:10.1007/978-3-642-01769-8_60 · Cited by 328
Fagon, J.-Y., Chastre, J., Trouillet, J.-L., Domart, Y., Dombret, M.-C., Bornet, M., & Gibert, C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1004 · Cited by 314
Tillie-Leblond, I., Marquette, C.-H., Perez, T., Scherpereel, A., Zanetti, C., Tonnel, A.-B., & Remy-Jardin, M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00005 · Cited by 312 · cited 1×
“Pulmonary embolism is an uncommon trigger for acute exacerbation (31), although in patients with acute exacerbation of unknown origin, the prevalence may be as high as 25% (32).”
BackgroundAntibiotic therapy in exacerbations of chronic obstructive pulmonary disease
Wagner, K. J. (1987) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(87)90153-3 · Cited by 301
Heart Failure and cHronic Obstructive Pulmonary Disease: An Ignored Combination?
Rutten, F. H., Cramer, M.-J. M., Lammers, J.-W. J., Grobbee, D. E., & Hoes, A. W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.01.010 · Cited by 291 · cited 3×
“Left heart failure is common because many patients with COPD have coronary artery disease and hypertensive heart disease as comorbid conditions (24).”
BackgroundBach, P. B., Brown, C., Gelfand, S. E., & McCrory, D. C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00016 · Cited by 287 · cited 2×
“Numerous clinical trials have supported the use of these drugs (2, 46).”
BackgroundStolz, D., Christ-Crain, M., Morgenthaler, N. G., Leuppi, J., Miedinger, D., Bingisser, R., Müller, C., Struck, J., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-2336 · Cited by 270
Hypercapnic acidosis and mortality in acute lung injury*
Kregenow, D. A., Rubenfeld, G. D., Hudson, L. D., & Swenson, E. R. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194533.75481.03 · Cited by 266 · cited 1×
“There is emerging evidence (although not universal) that a modest respiratory acidosis may ameliorate cellular injury (62, 63).”
BackgroundRole of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Wedzicha, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306030 · Cited by 261
Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
Ball, P. (1995) · Chest · doi:10.1378/chest.108.2_supplement.43s · Cited by 256 · cited 1×
“The average duration of an episode is 7 days, although it may take several months for the patient to return to baseline functional status (2, 3 , 6). More recent data from the National Emphysema Treatment Trial show that patients with severe emphysema and who are eligible for lung volume reduction surgery have 6.1 day…”
BackgroundInfluentialCost Effectiveness of Lung-Volume–Reduction Surgery for Patients with Severe Emphysema
(2003) · New England Journal of Medicine · doi:10.1056/nejmsa030448 · Cited by 234
Predictors of Outcome for Patients With COPD Requiring Invasive Mechanical Ventilation
Nevins, M. L., & Epstein, S. K. (2001) · Chest · doi:10.1378/chest.119.6.1840 · Cited by 231 · cited 1×
“In one large study, in hospital mortality in mechanically ventilated patients with AECOPD was almost 25%, 1-year mortality approached 40%, and 5-year mortality exceeded 70% (75).”
BackgroundMucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., Black, P. N., & Cates, C. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub4 · Cited by 225
In-Hospital and 5-Year Mortality of Patients Treated in the ICU for Acute Exacerbation of COPD
Ai-Ping, C., Lee, K.-H., & Lim, T.-K. (2005) · Chest · doi:10.1378/chest.128.2.518 · Cited by 221
COPD exacerbations {middle dot} 3: Pathophysiology
O'Donnell, D. E. (2006) · Thorax · doi:10.1136/thx.2005.041830 · Cited by 207
Sunyer, J., Sáez, M., Murillo, C., Castellsague, J., Martínez, F., & Antó, J. M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116730 · Cited by 205 · cited 1×
“It has been estimated that up to 9% of admissions with AECOPD may be due to atmospheric pollution, especially during the summer months (23).”
BackgroundExacerbations of Chronic Obstructive Pulmonary Disease
Anzueto, A., Sethi, S., & Martinez, F. J. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-003fm · Cited by 200
Prognosis in Chronic Obstructive Pulmonary Disease
Hodgkin, J. E. (1990) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00717-6 · Cited by 187
Wilkinson, T. M. A., Donaldson, G. C., Johnston, S. L., Openshaw, P. J. M., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1489oc · Cited by 187
Bronchodilator delivery in acute airflow obstruction. A meta-analysis
Turner, M. O. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.15.1736 · Cited by 179
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
Dev, D., Wallace, E., Sankaran, R., Cunniffe, J., Govan, J. R. W., Wathen, C. G., & Emmanuel, F. X. S. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90515-7 · Cited by 162
Pope, C. A., & Kanner, R. E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.6_pt_1.1336 · Cited by 159
MacNee, W., & Donaldson, K. (2000) · CHEST Journal · doi:10.1378/chest.117.5_suppl_2.390s · Cited by 122
Seneff, M. G. (1995) · JAMA · doi:10.1001/jama.274.23.1852 · Cited by 120
Gay, P. C., Joseph R, R., & Hubmayr, R. D. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.3.621 · Cited by 119
Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?
Rutschmann, O. T., Cornuz, J., Poletti, P., Bridevaux, P., Hügli, O., Qanadli, S. D., & Perrier, A. (2006) · Thorax · doi:10.1136/thx.2006.065557 · Cited by 117
Diagnosing Acute Pulmonary Embolism
Hartmann, I. J. C., Hagen, P. J., Melissant, C. F., Postmus, P. E., & Prins, M. H. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2006030 · Cited by 111 · cited 3×
“Congestive heart failure is an independent risk factor for survival in patients with COPD who had acute exacerbations requiring hospitalization ( 28 ).”
BackgroundInfluentialUçgun, İ., Metintaş, M., Moral, H., Alataş, F., Yıldırım, H., & Erginel, S. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.04.005 · Cited by 107 · cited 1×
“AECOPD episodes have been shown to accelerate FEV1 decline, to increase mortality (AECOPD episodes are the most common cause of death in COPD), and to have a profound influence on the decline in quality of life scores (4, 6, 73, 76).”
BackgroundAcute Exacerbations of Chronic Bronchitis
Ball, P. D., & Make, B. (1998) · CHEST Journal · doi:10.1378/chest.113.3_supplement.199s · Cited by 105 · cited 1×
“Another three-level staging system for AECOPD has been proposed that incorporates symptoms criteria and history of the disease and comorbidity (44).”
BackgroundA General Mathematical Model for Respiratory Dynamics Relevant to the Clinical Setting
Marini, J. J., & Crooke, P. S. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.1.14 · Cited by 103 · cited 1×
“PEEPi is a function of three variables: minute ventilation, inspiratory/ expiratory (I/E) time ratios, and expiratory time constants (resistance 3 compliance) (64).”
BackgroundVentilation-Perfusion Mismatching in Chronic Obstructive Pulmonary Disease during Ventilator Weaning
Torres, A., Reyes, A., Roca, J., Wagner, P. D., & Rodriguez-Roisin, R. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.5.1246 · Cited by 97
Infectious etiologies in acute exacerbation of COPD
Lieberman, D. B., Lieberman, D., Ben‐Yaakov, M., Lazarovich, Z., Hoffman, S., Ohana, B., Friedman, M. G., Dvoskin, B., Leinonen, M., & Boldur, I. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00255-3 · Cited by 97 · cited 1×
“Atypical microorganisms such as Mycoplasma pneumoniae and Chlamydia have been implicated in 5–15% and 5–10% of AECOPD cases, respectively (12, 16, 17).”
BackgroundBalter, M. S., Forge, J. L., Low, D. E., Mandell, L. A., Grossman, R. F., & the Chronic Bronchitis Working Group on behalf of the Canadian Thoracic Society and the Canadian Infectious Disease Society (2003) · Canadian Respiratory Journal · doi:10.1155/2003/108656 · Cited by 69 · cited 1×
“The Canadian Medical Association recently published guidelines for the management of AECOPD based on a five-stage severity system (43).”
MethodMeloni, F., Paschetto, E., Mangiarotti, P., Crepaldi, M., Morosini, M., Bulgheroni, A., & Fietta, A. M. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.1.70 · Cited by 45 · cited 1×
“Atypical microorganisms such as Mycoplasma pneumoniae and Chlamydia have been implicated in 5–15% and 5–10% of AECOPD cases, respectively (12, 16, 17).”
BackgroundVentilator-induced lung injury: from the bench to the bedside
Tremblay, L. N., & Slutsky, A. S. (2007) · Springer eBooks · doi:10.1007/3-540-37363-2_50 · Cited by 42
Ping, C. A., Lee, K. H., & Lim, T. K. (2006) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2006.01.021 · Cited by 39 · cited 1×
“Mortality is substantial in patients with COPD who require mechanical ventilation (although it is better than in patients with acute lung injury/acute respiratory distress syndrome) (74).”
BackgroundVestbo, J. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200510-107sf · Cited by 34 · cited 1×
“Some indicators of the need for hospitalization are shown in Table 2 (45).”
BackgroundShould Pulmonary Embolism be Suspected in Exacerbation of Chronic Obstructive Pulmonary Disease?
Mathieson, J. M. (2007) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.05.007 · Cited by 18
Therapeutic Hypercapnia: Careful Science, Better Trials
Kavanagh, B. P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2410003 · Cited by 14
Cost-Effectiveness of Lung-Volume-Reduction Surgery for Patients With Severe Emphysema
Eden, A. (2004) · Survey of Anesthesiology · doi:10.1097/01.sa.0000140526.07826.fd · Cited by 13
Right Ventricular Function in Patients With Severe COPD Evaluated for Lung Transplantation
Keller, C. A., Ohar, J. A., Ruppel, G. L., Wittry, M. D., & Goodgold, H. M. (1995) · CHEST Journal · doi:10.1378/chest.107.6.1510 · Cited by 12
Corticosteroid Therapy and Chronic Obstructive Pulmonary Disease
MacIntyre, N. R. (2006) · Respiratory Care · doi:10.4187/respcare.06510289 · Cited by 9
Self-citation
Cited by
Benralizumab for the Prevention of COPD Exacerbations
Criner, G. J., Celli, B. R., Brightling, C. E., Agusti, A., Papi, A., Singh, D., Sin, D. D., Vogelmeier, C. F., Sciurba, F. C., Bafadhel, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905248 · Cited by 351
Nasal high flow clears anatomical dead space in upper airway models
Möller, W., Celik, G., Feng, S., Bartenstein, P., Meyer, G., Eickelberg, O., Schmid, O., & Tatkov, S. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00934.2014 · Cited by 320
Metadata
- Authors
- MacIntyre, N., & Huang, Y. C.
- Venue
- Proceedings of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-01
- Volume
- 5
- Issue
- 4
- Pages
- 530-535
- ISSN
- 1546-3222 (ISSN-L)
- 1943-5665
- OpenAlex
- W2129412411
- Cited by
- 159
- References
- 72
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.